These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1627212)

  • 21. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
    Palmer AL; Gay H; Currier MM
    J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.
    Bennetto-Hood C; Bryson YJ; Stek A; King JR; Mirochnick M; Acosta EP
    HIV Clin Trials; 2009; 10(1):41-7. PubMed ID: 19362995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
    Barzilai A; Sperling RS; Hyatt AC; Wedgwood JF; Reidenberg BE; Hodes DS
    Pediatr Infect Dis J; 1990 Dec; 9(12):931-3. PubMed ID: 2277754
    [No Abstract]   [Full Text] [Related]  

  • 25. ZDV reduces maternal transmission.
    AIDS Patient Care; 1994 Jun; 8(3):164. PubMed ID: 11362140
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group.
    O'Sullivan MJ; Boyer PJ; Scott GB; Parks WP; Weller S; Blum MR; Balsley J; Bryson YJ
    Am J Obstet Gynecol; 1993 May; 168(5):1510-6. PubMed ID: 8098905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zidovudine for the reduction of perinatal transmission of human immunodeficiency virus.
    Yoder DK
    J Tenn Med Assoc; 1995 Jul; 88(7):272, 274. PubMed ID: 7658693
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on vertical HIV transmission.
    Groginsky E; Bowdler N; Yankowitz J
    J Reprod Med; 1998 Aug; 43(8):637-46. PubMed ID: 9749412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
    Shapiro RL; Holland DT; Capparelli E; Lockman S; Thior I; Wester C; Stevens L; Peter T; Essex M; Connor JD; Mirochnick M
    J Infect Dis; 2005 Sep; 192(5):720-7. PubMed ID: 16088821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination.
    André-Schmutz I; Dal-Cortivo L; Six E; Kaltenbach S; Cocchiarella F; Le Chenadec J; Cagnard N; Cordier AG; Benachi A; Mandelbrot L; Azria E; Bouallag N; Luce S; Ternaux B; Reimann C; Revy P; Radford-Weiss I; Leschi C; Recchia A; Mavilio F; Cavazzana M; Blanche S
    J Infect Dis; 2013 Jul; 208(2):235-43. PubMed ID: 23559464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
    Fauchet F; Treluyer JM; Valade E; Benaboud S; Pannier E; Firtion G; Foissac F; Bouazza N; Urien S; Hirt D
    Br J Clin Pharmacol; 2014 Dec; 78(6):1387-96. PubMed ID: 25040510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
    Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):433-40. PubMed ID: 9859956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.
    Lopez-Anaya A; Unadkat JD; Schumann LA; Smith AL
    J Acquir Immune Defic Syndr (1988); 1990; 3(10):959-64. PubMed ID: 2398459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection.
    Acosta EP; Schwebke K; Henry K; Fletcher CV
    J Infect Dis; 1996 Sep; 174(3):673. PubMed ID: 8769638
    [No Abstract]   [Full Text] [Related]  

  • 35. Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound.
    Pons JC; Taburet AM; Singlas E; Delfraissy JF; Papiernik E
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(3):229-31. PubMed ID: 1879598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplacental transfer of zidovudine in the near-term pregnant baboon.
    Hankins GD; Lowery CL; Scott RT; Morrow WR; Carey KD; Leland MM; Colvin EV
    Am J Obstet Gynecol; 1990 Sep; 163(3):728-32. PubMed ID: 2403153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High exposure to zidovudine during the first 2 weeks of life and concentration-toxicity relationships.
    Hirt D; Warszawski J; Firtion G; Giraud C; Chappuy H; Lechenadec J; Benaboud S; Urien S; Blanche S; Tréluyer JM
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):555-62. PubMed ID: 23481669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of zidovudine in HIV-positive patients with liver disease.
    Bareggi SR; Cinque P; Mazzei M; D'Arminio A; Ruggieri A; Pirola R; Nicolin A; Lazzarin A
    J Clin Pharmacol; 1994 Jul; 34(7):782-6. PubMed ID: 7929874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.
    Chappuy H; Tréluyer JM; Jullien V; Dimet J; Rey E; Fouché M; Firtion G; Pons G; Mandelbrot L
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4332-6. PubMed ID: 15504861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patients.
    Wintergerst U; Rolinski B; Bogner JR; Notheis G; Goebel FD; Roscher AA; Belohradsky BH
    Antimicrob Agents Chemother; 1997 May; 41(5):1143-5. PubMed ID: 9145885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.